GI-RADS联合血清肿瘤标志物鉴别卵巢肿块良恶性的价值

doi:10.7517/issn.1674-0475.210516

影像科学与光化学 ›› 2021, Vol. 39 ›› Issue (6): 916-919.DOI: 10.7517/issn.1674-0475.210516

• 综述与论文 • 上一篇

GI-RADS联合血清肿瘤标志物鉴别卵巢肿块良恶性的价值

闫玲, 孙建霞, 张汀, 贾化平

中国人民解放军战略支援部队特色医学中心, 北京 100101

收稿日期:2021-05-16 出版日期:2021-11-15 发布日期:2021-11-11
通讯作者: 贾化平

Clinical Application Value of GI-RADS Reporting System Combined with Serum Tumor Markers in Differentiating Benign and Malignant Ovarian Masses

YAN Ling, SUN Jianxia, ZHANG Ting, JIA Huaping

PLA Strategic Support Force Characteristic Medical Center, Beijing 100101, P. R. China

Received:2021-05-16 Online:2021-11-15 Published:2021-11-11

摘要/Abstract

摘要： 本研究探讨妇科影像报告与数据系统（GI-RADS）联合血清肿瘤标志物在卵巢肿块良恶性鉴别诊断中的应用价值。回顾分析卵巢肿块患者132例的超声影像资料。良性肿块患者90例，恶性肿块患者42例；GI-RADS联合血清肿瘤标志物以并联方式诊断恶性的灵敏性、特异性、准确性、阳性预测值和阴性预测值分别为83.33%、74.44%、77.27%、60.34%和90.54%；以串联方式诊断恶性的灵敏性、特异性、准确性、阳性预测值和阴性预测值分别为64.29%、90.00%、81.82%、75.00%和84.38%。GI-RADS联合血清肿瘤标志物鉴别诊断卵巢肿块良恶性具有较好的临床应用价值。

关键词: 妇科影像报告与数据系统, 血清肿瘤标志物, 卵巢

Abstract: This study was to investigate the value of gynecological imaging reporting and data system (GI-RADS) combined with serum tumor markers in the differential diagnosis of benign and malignant ovarian masses. The ultrasonic imaging data of 132 patients with ovarian masses were reviewed. There were 90 patients with benign masses and 42 patients with malignant masses. the sensitivity, specificity, accuracy, positive predictive value and negative predictive value of parallel diagnosis of GI-RADS combined with serum tumor markers were 83.33%, 74.44%, 77.27%, 60.34% and 90.54%, respectively. The sensitivity, specificity, accuracy, positive predictive value and negative predictive value of tandem method were 64.29%, 90.00%, 81.82%, 75.00% and 84.38%, respectively. GI-RADS combined with serum tumor markers has good clinical application value in the differential diagnosis of benign and malignant ovarian masses.

Key words: Gynecological Imaging Reporting and Data System, serum tumor markers, ovary

闫玲, 孙建霞, 张汀, 贾化平. GI-RADS联合血清肿瘤标志物鉴别卵巢肿块良恶性的价值[J]. 影像科学与光化学, 2021, 39(6): 916-919.

YAN Ling, SUN Jianxia, ZHANG Ting, JIA Huaping. Clinical Application Value of GI-RADS Reporting System Combined with Serum Tumor Markers in Differentiating Benign and Malignant Ovarian Masses[J]. IMAGING SCIENCE AND PHOTOCHEMISTRY, 2021, 39(6): 916-919.

参考文献

[1] 胡昌锋, 邬玉, 张良成. 彩色多普勒超声评分系统在卵巢良恶性肿块鉴别诊断中的应用[J]. 海南医学, 2019, 30(9):1170-1173.
[2] 高明, 张荣, 韩转宁, 等. 卵巢肿块超声造影参数与VEGF和HIF-1α同步相关性研究[J]. 中国肿瘤临床与康复, 2020, 27(8):941-944.
[3] 左金, 闫海龙, 韩东明. DCE-MRI在卵巢交界性肿瘤与上皮性卵巢癌中的鉴别诊断价值[J]. 医学影像学杂志, 2020, 30(5):798-802.
[4] 陆芳, 彭梅, 王丽华. 超声GI-RADS分类结合血清HE4与CA125检测对卵巢单房囊实性肿瘤的诊断价值[J]. 重庆医学, 2019, 48(1):143-145.
[5] Marko J, Marko K I, Pachigolla S L, et al. Mucinous neoplasms of the ovary:Radiologic-pathologic correlation[J]. Radio Graphics, 2019, 39(4):982-997.
[6] Asada T, Yamada T, Kumano R. Primary ovarian leiomyoma with predominant cystic change[J]. Radiology Case Reports, 2019, 14(11):1315-1319.
[7] Lawrence A E, Minneci P C, Deans K J. Ovary-sparing surgery for benign pediatric ovarian masses[J]. Current Opinion in Pediatrics, 2019, 31(3):386-390.
[8] 季春艳, 曾艳, 程瑶瑶, 等. 超声检查联合CA125、OPN检测在卵巢癌诊断中的应用[J]. 中国实验诊断学, 2020, 24(4):600-602.
[9] Baumann W, von Hasselbach H. Diagnosis and therapy of benign pedunculated tumors of the upper esophagus[J].Langenbecks Archiv Fur Klinische Chirurgie Vereinigt Mit Deutsche Zeitschrift Fur Chirurgie, 1953, 274(5):347-352.
[10] 侯红梅, 乔亚男, 董敏. 经阴道彩色多普勒超声联合肿瘤标志物CA125诊断卵巢上皮性肿瘤的临床价值[J]. 医学影像学杂志, 2019, 29(2):286-289.
[11] Nakache G, Yahav G, Siloni G H, et al. The use of fluorescence lifetime technology in benign and malignant thyroid tissues[J]. The Journal of Laryngology & Otology, 2019, 133(8):696-699.
[12] Mallinger W D, Quick C M, et al. Benign and premalignant lesions of the endometrium[J]. Surgical Pathology Clinics, 2019, 12(2):315-328.
[13] 李敏, 冯岗, 李汶珊, 等.多普勒彩超联合血清CA125、TSGF在卵巢癌诊断中的应用分析[J].四川医学, 2020, 41(12):1287-1290.
[14] 黄冰冰, 陈秋月, 吕国荣. 比较超声妇科影像报告和数据系统分类与恶性风险指数4鉴别卵巢良恶性肿块的价值[J]. 中国医学影像技术, 2019, 35(4):569-572.
[15] 谢艳秋, 任敏, 王大维, 等. 超声改良妇科影像学报告和数据系统(mGI-RADS)分级诊断卵巢肿瘤的临床应用价值[J]. 中华超声影像学杂志, 2020, 29(5):421-426.

GI-RADS联合血清肿瘤标志物鉴别卵巢肿块良恶性的价值

Clinical Application Value of GI-RADS Reporting System Combined with Serum Tumor Markers in Differentiating Benign and Malignant Ovarian Masses

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 8

编辑推荐

Metrics

本文评价

[1]	范方裕, 蒲英梅, 周柱玉, 辛艳芬, 夏纪筑. Finkler超声评分联合LMTK2基因在诊断上皮性卵巢癌中的应用[J]. 影像科学与光化学, 2022, 40(5): 1062-1066.
[2]	封捷, 李梦双, 段新秀. DCE-MRI对上皮性卵巢癌的诊断价值及与微血管密度的关系[J]. 影像科学与光化学, 2022, 40(4): 832-836.
[3]	周利, 宣之东, 李秀娟. 超声联合CA125、HE4检测对卵巢性索间质肿瘤的诊断分析[J]. 影像科学与光化学, 2022, 40(3): 545-549.
[4]	丁迎春, 鲍玲玲, 燕小朋. 腹部彩超联合CA125诊断卵巢浆液性肿瘤的研究[J]. 影像科学与光化学, 2022, 40(1): 133-137.
[5]	林栋, 黄家杰, 吴尚文, 覃尼, 许华莉. IVIM-DWI参数对卵巢良/恶性肿瘤的诊断效能及与肿瘤标志物、临床病理因素相关性分析[J]. 影像科学与光化学, 2021, 39(3): 407-411.
[6]	王帅, 程锦. CT、阴道超声对卵巢良恶性肿瘤的诊断效能及与肿瘤标志物相关性分析[J]. 影像科学与光化学, 2021, 39(3): 450-454.
[7]	胥春霞, 赖欣. 彩色多普勒(TVCDU)、三维彩色能量成像(3D-CPA)联合脉冲多普勒(PW)鉴别卵巢占位病变性质及对恶性病变术前分期的评估价值[J]. 影像科学与光化学, 2021, 39(3): 455-459.
[8]	韩龄锋, 赵俊. 彩色多普勒超声联合核磁共振对卵巢肿瘤的鉴别诊断效能[J]. 影像科学与光化学, 2020, 38(4): 694-697.